Pediatric Bioavailability
Pediatric Bioavailability is the proportion of an administered drug dose that reaches the systemic circulation intact in a pediatric population, distinguishing it from adult bioavailability by accounting for age-related physiological, metabolic, and developmental factors affecting absorption, distribution, and clearance in infants, children, and adolescents.
117
Publications
4.2K
Citations
634
Authors
268
Institutions
Publications per year
2017–2026
22
117
Moustapha Hassan, Per Ljungman, P Bolme et al. · Blood · 1994 · 167 citations · Full text
Xiaoyun Ye, Kayoko Kato, Lee-Yang Wong et al. · International Journal of Hygiene and Environmental Health · 2017 · 115 citations · Full text
1–5 of 117
634
4
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 634
268

Karolinska Institutet
Stockholm, Sweden
6 h-index
19 publications
718 citations

University of Cape Town
Rondebosch, South Africa
4 h-index
15 publications
494 citations
University College London
London, United Kingdom
4 h-index
23 publications
1.1K citations

The University of Western Australia
Perth, Australia
3 h-index
10 publications
444 citations

Cincinnati Children's Hospital Medical Center
Cincinnati, United States
3 h-index
3 publications
122 citations
Curtin University
Perth, Australia
3 h-index
4 publications
147 citations
Desmond Tutu HIV Foundation
Cape Town, South Africa
3 h-index
11 publications
312 citations

Children's Mercy Hospital
Kansas City, United States
3 h-index
13 publications
292 citations
1–8 of 268
Repository · 12 publications · 265 citations
10
h-index
AAC · 8 publications · 366 citations
8
h-index
6 publications · 188 citations
6
h-index
4 publications · 276 citations
4
h-index
CPT · 4 publications · 121 citations
4
h-index
1–5